Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1987-4-17
pubmed:abstractText
Three new immunogens which were prepared by conjugation of the carboxymethyl oxime (CMO) derivatives of HT-2 toxin, T-2 tetraol (T-2 4ol), and T-2 tetraol tetraacetate (T-2 4Ac) to bovine serum albumin (BSA) were tested for the production of antibodies against the major metabolites of T-2 toxin. Antibodies against HT-2 toxin and T-2 4Ac were obtained from rabbits 5 to 10 weeks after immunizing the animals with CMO-HT-2-BSA and CMO-T-2 4Ac-BSA conjugates. Immunization with CMO-T-2 4ol-BSA resulted in no antibody against T-2 4ol. The antibody produced against HT-2 toxin had great affinity for HT-2 toxin as well as good cross-reactivity with T-2 toxin. The relative cross-reactivities of anti-HT-2 toxin antibody with HT-2 toxin, T-2 toxin, iso-T-2 toxin, acetyl-T-2 toxin, 3'-OH HT-2, 3'-OH T-2, T-2 triol, and 3'-OH acetyl-T-2, were 100, 25, 10, 3.3, 0.25, 0.15, 0.12 and 0.08%, respectively. Antibody against CMO-T-2 4Ac was very specific for T-2 4Ac and had less than 0.1% cross-reactivity with T-2 toxin, HT-2 toxin, acetyl-T-2 toxin, diacetoxyscirpenol, deoxynivalenol, and deoxynivalenol triacetate as compared with T-2 4Ac. The detection limits for HT-2 toxin and T-2 4ol by radioimmunoassay were approximately 0.1 and 0.5 ng per assay, respectively.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-3954337, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-3980403, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-4026286, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-4161471, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-4856716, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-5160724, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-599145, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-6508286, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-6508287, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-6508304, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-6614901, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-6696412, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-6742830, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-6830221, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-7125654, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-7160825, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-7196370, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-7204297, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-7240074, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-760628, http://linkedlifedata.com/resource/pubmed/commentcorrection/3827243-881503
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0099-2240
pubmed:author
pubmed:issnType
Print
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
17-21
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Production and characterization of antibodies against HT-2 toxin and T-2 tetraol tetraacetate.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't